Artículos por temáticas
En este apartado encontrará una actualización mensual de artículos sobre Trastornos del Movimiento clasificados según los 11 tipos establecidos por la International Parkinson & Movement Disorder Society.
FILTRAR POR:
Tema
Fisiopatología
465 ARTíCULOS , VIENDO DEL 136 AL 150
Association and heterogeneity at the GAPDH locus in Alzheimer's disease
Allen M, Cox C, Belbin O, Ma L, Bisceglio GD, Wilcox SL, Howell CC, Hunter TA, Culley O, Walker LP, Carrasquillo MM, Dickson DW, Petersen RC, Graff-Radford NR, Younkin SG, Ertekin-Taner N.
Neurobiol Aging. 2012 Jan;33(1):203.e25-33. doi: 10.1016/j.neurobiolaging.2010.08.002. Epub 2010 Sep 23.
0
0
0
Guan F, Gu J, Hu F, Zhu Y, Wang W.
Mol Biol Rep. 2012 Jun;39(6):6661-9. doi: 10.1007/s11033-012-1472-8.
0
0
0
Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature
Wyss-Coray T, Rogers J.
Cold Spring Harb Perspect Med. 2012 Jan;2(1):a006346. doi: 10.1101/cshperspect.a006346.
0
0
0
Delirium associated with duloxetine in a depressed patient with Alzheimer's dementia
Suzuki Y, Saito M, Someya T.
Psychiatry Clin Neurosci. 2012 Mar;66(2):166. doi: 10.1111/j.1440-1819.2011.02316.x.
0
0
0
White matter predictors of cognitive functioning in older adults
Meier IB, Manly JJ, Provenzano FA, Louie KS, Wasserman BT, Griffith EY, Hector JT, Allocco E, Brickman AM.
J Int Neuropsychol Soc. 2012 May;18(3):414-27. doi: 10.1017/S1355617712000227. Epub 2012 Mar 6.
0
0
0
Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease
Brewer GJ.
Biofactors. 2012 Mar-Apr;38(2):107-13. doi: 10.1002/biof.1005. Epub 2012 Mar 22.
0
0
0
Sudo E, Hanabusa H.
Nihon Ronen Igakkai Zasshi. 2012;49(1):119-22. doi: 10.3143/geriatrics.49.119.
0
0
0
The role of inflammatory processes in Alzheimer's disease
Broussard GJ, Mytar J, Li RC, Klapstein GJ.
Inflammopharmacology. 2012 Jun;20(3):109-26. doi: 10.1007/s10787-012-0130-z. Epub 2012 Apr 26.
0
0
0
Martyr A, Clare L.
Dement Geriatr Cogn Disord. 2012;33(2-3):189-203. doi: 10.1159/000338233. Epub 2012 May 10.
0
0
0
Single-cell and regional gene expression analysis in Alzheimer's disease
Kwong R, Lupton MK, Janitz M.
Cell Mol Neurobiol. 2012 May;32(4):477-89. doi: 10.1007/s10571-012-9797-3. Epub 2012 Jan 22.
0
0
0
Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia
Neri M, Bonassi S, Russo P.
Curr Drug Targets. 2012 May;13(5):636-43. doi: 10.2174/138945012800398928.
0
0
0
Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease
de la Monte SM.
Curr Alzheimer Res. 2012 Jan;9(1):35-66. doi: 10.2174/156720512799015037.
0
0
0
Di Bona D, Rizzo C, Bonaventura G, Candore G, Caruso C.
J Alzheimers Dis. 2012;29(4):751-9. doi: 10.3233/JAD-2012-111838.
0
0
0
Effect of genetic variation in LRRTM3 on risk of Alzheimer disease
Reitz C, Conrad C, Roszkowski K, Rogers RS, Mayeux R.
Arch Neurol. 2012 Jul;69(7):894-900. doi: 10.1001/archneurol.2011.2463.
0
0
0
Global Alzheimer Research Summit: basic and clinical research: present and future Alzheimer research
Gonsalves D, Jovanovic K, Da Costa Dias B, Weiss SF.
Prion. 2012 Jan-Mar;6(1):7-10. doi: 10.4161/pri.6.1.18854.
0
0
0
Comentarios
En ningún caso la información facilitada constituye asesoramiento por parte de Zambon
Con el aval de:
En colaboración con:
